Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-06-19

Clinical Trial Update: Headache Inducing Effect of Cromakalim in Migraine Patients [NA]

View source ↗

Summary

A completed trial evaluating cromakalim in migraine patients observed a headache-inducing effect, signaling a potential safety risk.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cromakalim (Cromakalim)

Snippet

Sponsor: Danish Headache Center | Conditions: Headache, Migraine | NA | Status: COMPLETED